GLYCOSELECT
GlycoSeLect specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs), enhanced tools for the analysis and selective purification of glycosylated biomolecules. RPLs have a broad spectrum of applications across the life sciences in: - Basic R&D – Glycobiology & Glycoproteomics. - Biomarker Discover & Biomedical Diagnostics. - The Biopharmaceutical Industry. - Vaccines - Cosmetics GlycoSeLect's Recombinant Prokaryotic Lectins (RPLs) present significant adv... antages over existing commercially available lectins products including: - Simplified, rapid & cost effective production through recombinant expression in Escherichia coli. - High purity & consistent performance. - Genetically enhanced glycan binding properties (specificity & affinity). - Scalable production facilitating utilization for large scale applications.
GLYCOSELECT
Industry:
Biotechnology Life Science Medical
Founded:
2013-10-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.glycoselect.com
Total Employee:
1+
Status:
Active
Contact:
+353877902652
Email Addresses:
[email protected]
Total Funding:
450 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
KBI Biopharma
KBI Biopharma investment in Seed Round - GlycoSeLect
Enterprise Ireland
Enterprise Ireland investment in Seed Round - GlycoSeLect
Official Site Inspections
http://www.glycoselect.com
- Host name: aqua.webhostingireland.ie
- IP address: 91.210.232.215
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02